Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Laura Hughes to Middle Aged

This is a "connection" page, showing publications Laura Hughes has written about Middle Aged.

 
Connection Strength
 
 
 
0.268
 
  1. Hughes LE, Adams NE, Rouse MA, Naessens M, Shaw A, Murley AG, Cope TE, Holland N, Nesbitt D, Street D, Whiteside DJ, Rowe JB. GABAergic modulation of beta power enhances motor adaptation in frontotemporal lobar degeneration. Alzheimers Dement. 2025 05; 21(5):e14531.
    View in: PubMed
    Score: 0.046
  2. Hughes LE, Rittman T, Robbins TW, Rowe JB. Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia. Brain. 2018 08 01; 141(8):2486-2499.
    View in: PubMed
    Score: 0.029
  3. Hughes LE, Rittman T, Regenthal R, Robbins TW, Rowe JB. Improving response inhibition systems in frontotemporal dementia with citalopram. Brain. 2015 Jul; 138(Pt 7):1961-75.
    View in: PubMed
    Score: 0.024
  4. Hughes LE, Rowe JB, Ghosh BC, Carlyon RP, Plack CJ, Gockel HE. The binaural masking level difference: cortical correlates persist despite severe brain stem atrophy in progressive supranuclear palsy. J Neurophysiol. 2014 Dec 15; 112(12):3086-94.
    View in: PubMed
    Score: 0.022
  5. Hughes LE, Rowe JB. The impact of neurodegeneration on network connectivity: a study of change detection in frontotemporal dementia. J Cogn Neurosci. 2013 May; 25(5):802-13.
    View in: PubMed
    Score: 0.020
  6. Hughes LE, Altena E, Barker RA, Rowe JB. Perseveration and choice in Parkinson's disease: the impact of progressive frontostriatal dysfunction on action decisions. Cereb Cortex. 2013 Jul; 23(7):1572-81.
    View in: PubMed
    Score: 0.019
  7. Hughes LE, Nestor PJ, Hodges JR, Rowe JB. Magnetoencephalography of frontotemporal dementia: spatiotemporally localized changes during semantic decisions. Brain. 2011 Sep; 134(Pt 9):2513-22.
    View in: PubMed
    Score: 0.018
  8. Hughes LE, Barker RA, Owen AM, Rowe JB. Parkinson's disease and healthy aging: independent and interacting effects on action selection. Hum Brain Mapp. 2010 Dec; 31(12):1886-99.
    View in: PubMed
    Score: 0.016
  9. Whiteside DJ, Rouse MA, Jones PS, Coyle-Gilchrist I, Murley AG, Stockton K, Hughes LE, Bethlehem RAI, Warrier V, Lambon Ralph MA, Rittman T, Rowe JB. The presymptomatic and early manifestations of semantic dementia. Brain. 2026 May 05; 149(5):1663-1678.
    View in: PubMed
    Score: 0.013
  10. Lanskey JH, Jafarian A, Hughes LE, Karadag M, Kocagoncu E, Rouse MA, Adams NE, Naessens M, Raymont V, Woolrich M, Singh KD, Henson RN, Rowe JB. Alzheimer's disease and memantine effects on NMDA-receptor blockade: non-invasive in vivo insights from magnetoencephalography. Mol Psychiatry. 2026 Mar; 31(3):1587-1596.
    View in: PubMed
    Score: 0.012
  11. Perry A, Hughes LE, Adams NE, Naessens M, Kloosterman NA, Rouse MA, Murley AG, Street D, Jones PS, Rowe JB. Frontotemporal lobar degeneration changes neuronal beta-frequency dynamics during the mismatch negativity response. Neuroimage Clin. 2024; 44:103671.
    View in: PubMed
    Score: 0.011
  12. Shaw AD, Hughes LE, Moran R, Coyle-Gilchrist I, Rittman T, Rowe JB. In Vivo Assay of Cortical Microcircuitry in Frontotemporal Dementia: A Platform for Experimental Medicine Studies. Cereb Cortex. 2021 02 05; 31(3):1837-1847.
    View in: PubMed
    Score: 0.009
  13. Adams NE, Hughes LE, Phillips HN, Shaw AD, Murley AG, Nesbitt D, Cope TE, Bevan-Jones WR, Passamonti L, Rowe JB. GABA-ergic Dynamics in Human Frontotemporal Networks Confirmed by Pharmaco-Magnetoencephalography. J Neurosci. 2020 02 19; 40(8):1640-1649.
    View in: PubMed
    Score: 0.008
  14. Sami S, Williams N, Hughes LE, Cope TE, Rittman T, Coyle-Gilchrist ITS, Henson RN, Rowe JB. Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype. Brain. 2018 08 01; 141(8):2500-2510.
    View in: PubMed
    Score: 0.007
  15. Rae CL, Nombela C, Rodríguez PV, Ye Z, Hughes LE, Jones PS, Ham T, Rittman T, Coyle-Gilchrist I, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Atomoxetine restores the response inhibition network in Parkinson's disease. Brain. 2016 08; 139(Pt 8):2235-48.
    View in: PubMed
    Score: 0.006
  16. Borchert RJ, Rittman T, Passamonti L, Ye Z, Sami S, Jones SP, Nombela C, Vázquez Rodríguez P, Vatansever D, Rae CL, Hughes LE, Robbins TW, Rowe JB. Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease. Neuropsychopharmacology. 2016 07; 41(8):2171-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)